Sandoz Inc. penalized in United States of America in Mar, 2020

195 Mn

 Penalty (US$)

0 Months

 Imprisonments

 United States of America

 Country of Event

Reason:
Bid Rigging, Price Fixing


Sandoz Inc. was penalized in United States of America dated March 02, 2020.
From 2013 to 2015, Sandoz participated in a conspiracy with a generic drug company based in New York and other individuals. Sandoz admitted that drugs affected by this conspiracy included clobetasol (cream, emollient cream, gel, ointment, and solution), desonide ointment, and nystatin triamcinolone cream. Sandoz was also a part of the conspiracy with Kavod Pharmaceuticals LLC (formerly known as Rising Pharmaceuticals) to allocate customers and fix prices of benazepril HCTZ. Rising was charged and entered into a deferred prosecution agreement in December 2019 for its participation in the same conspiracy. Sandoz also had a part in a conspiracy with a generic drug company based in Michigan. Sandoz admitted that drugs affected by this conspiracy included desonide ointment. Sandoz participated in a conspiracy with a generic drug company based in Pennsylvania. Sandoz admitted that drugs affected by this conspiracy included tobramycin inhalation solution.
On March 02, 2020, Sandoz entered a deferred prosecution agreement resolving the charges against it and agreed to pay a fine of USD 195 million. It also admitted that its sales affected by the charged conspiracies exceeded USD 500 million.
Important Dates:
Schemes - 2013 to 2015
Agreement - March 02, 2020

Regulating Agency:

U.S. Department of Justice

Entity Involved:

Sandoz Inc.

Source:
www.justice.gov